The clinical evaluation of Medical Nebulizer should be subject to ‘Medical Device Clinical Evaluation Technical Guideline’ (CFDA 12th Notification attachment, 2014).
The Requirements of the Medical Nebulizer Clinical Evaluation Compiling.
1. Submit the comparison documents of the declared product related information and the product description in the ‘Catalog of Class II Medical Devices Exempted from Clinical Trials’. The comparison content should explain the declared products belongs to the products in ‘Catalog of Class II Medical Devices Exempted from Clinical Trials’.
2. Submit the comparison explanation about the declared products and the similar listed products included in the ‘Catalog of Class II Medical Devices Exempted from Clinical Trials’. The comparison explanation should include ‘The Comparison Chart of the Declared Products and The Similar Listed Products Included in the ‘Catalog of Class II Medical Devices Exempted from Clinical Trials’ and related supporting documents.
The Comparison Chart of the Declared Products and the Similar Listed Products Included in the ‘Catalog of Class II Medical Devices Exempted from Clinical Trials’
Comparison Items | Similar Listed Products(in China) | Declared Products | Differences | Overview of Supporting Documents |
Basic principles (working principle/action mechanism) | ||||
Structural composition | ||||
The skin contacting manufacturing materials | ||||
Performance requirement | ||||
Sterilization or sterilization | ||||
Applicable scope | ||||
Usage | ||||
Others (add comparison items based on the actual situation)… |
How to Certify the Equality
- The submitted documents shall be able to certify that the declared products have equality with the products described in the ‘Catalog of Class II Medical Devices Exempted from Clinical Trials’.
- If the declared products have any differences in the structural composition, performance requirements, manufacturing materials, applicable scope and etc. the applicants should explain the differences in details. And also submit the proofing documents to explain that the differences will not affect the equality. At the same time, applicants should explain the differences will not have new risk on the product safety and effectiveness. If the differences might have risk on the product safety and effectiveness, the applicants should supplement the clinical evaluation documents and clinical trials documents based on the risk level.
Related links:
- Foreign Medical Device Applicant are Required to Supplement the Chinese Information to CFDA
- Preparation of Medical Device Technical Requirements
- Regulations & Know-how
- Classification and Category of Medical Devices in China
- Medical Nebulizer Registration Guideline
- Free Webinar! CFDA New Notification about Standardize the Use of Chinese Name for Foreign Medical Device CFDA Registration
* If you have any comments or questions, please contact us at md@cirs-group.com.